← Insider Monitor
LRMR
Larimar Therapeutics, Inc.
Recent activity from public SEC and congressional filings.
7
Insider trades
0
Congress trades
Corporate Insider Trades
Open-market purchases and sales by directors, officers, and other company insiders.
| Insider | Type | Value | Shares / Price | Date |
|---|---|---|---|---|
| THOMAS FRANK EDirector | Buy | $22K | 8,000at $2.73 | Nov 11, 2026 |
| Shankar GopiChief Development Officer | Buy | $14K | 5,000at $2.71 | Nov 11, 2026 |
| Celano MichaelChief Financial Officer | Buy | $50K | 18,460at $2.71 | Nov 11, 2026 |
| Harlow John B. Jr.President and COO | Buy | $50K | 17,800at $2.80 | Nov 11, 2026 |
| Truitt JosephDirector | Buy | $10K | 3,500at $2.80 | Nov 11, 2026 |
| BEN-MAIMON CAROLEPresident and CEO | Buy | $50K | 18,050at $2.77 | Nov 11, 2026 |
| Hamilton Thomas EdwardDirector | Buy | $187K | 70,000at $2.67 | Nov 12, 2026 |
Source: SEC EDGAR Form 4 filings
Congressional Trades
Recent disclosures by members of the U.S. House and Senate.
No recent congressional disclosures found for LRMR.
Source: Senate eFD and House Clerk STOCK Act disclosures
Get notable LRMR activity by email
Free alerts for the insider and congressional trades worth watching.
For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.